定义导管内乳头状黏液性肿瘤来源胰腺癌淋巴结切除与检查的最小及最佳阈值:一项多中心回顾性分析
这项多中心回顾性研究纳入341例接受 upfront 手术的导管内乳头状黏液性肿瘤(IPMN)来源胰腺导管腺癌(PDAC)患者,旨在确定淋巴结切除的最小和最佳阈值。最小准确分期所需淋巴结数为10枚(P=0.040),≥20枚与总生存改善相关(80.3 vs 37.2个月,P<0.001)。最佳淋巴结切除与总生存(HR 0.57,95%CI 0.39-0.83)和无复发生存(HR 0.70,95%CI 0.51-0.97)改善相关。
要点
- IPMN来源PDAC确保准确淋巴结分期的最小淋巴结数为10枚(P=0.040)。
- ≥20枚淋巴结与总生存改善相关(80.3 vs 37.2个月,P<0.001)。
- 胰十二指肠切除术和全胰腺切除术的最佳淋巴结阈值分别为20枚(P<0.001)和25枚(P=0.008)。
核心结论
- 在IPMN来源PDAC中,淋巴结切除至少10枚可减少分期不足,至少20枚与生存改善相关。
- 具体而言,胰十二指肠切除术和全胰腺切除术的最佳淋巴结阈值分别为20枚和25枚。
研究设计与样本
- 多中心回顾性研究,纳入连续接受 upfront 手术的IPMN来源PDAC患者341例。
- 最小淋巴结切除阈值定义为观察到显著淋巴结阳性差异的最大淋巴结数;最佳阈值采用最大选择 log-rank 统计量推导(以最大化生存)。
主要发现
- 在341例切除的IPMN来源PDAC患者中,确保准确淋巴结分期所需的最小淋巴结数为10枚(P=0.040)。
- ≥20枚淋巴结是与总生存改善相关的最佳数量(80.3 vs 37.2个月,P<0.001)。
- 多变量 Cox 回归显示,最佳淋巴结切除与总生存改善相关(HR 0.57,95%CI 0.39-0.83),并与无复发生存改善相关(HR 0.70,95%CI 0.51-0.97)。
- 亚组分析中,胰十二指肠切除术、远端胰腺切除术和全胰腺切除术的最佳淋巴结切除阈值分别为20枚(P<0.001)、23枚(P=0.160)和25枚(P=0.008)。
关键数值与推荐
- IPMN来源PDAC准确淋巴结分期的最小淋巴结数为10枚(P=0.040)。
- 最佳淋巴结切除阈值为≥20枚淋巴结,与总生存改善相关(80.3 vs 37.2个月,P<0.001)。
- 胰十二指肠切除术最佳阈值为20枚(P<0.001),全胰腺切除术为25枚(P=0.008),远端胰腺切除术为23枚(P=0.160)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To establish minimal and optimal lymphadenectomy thresholds for intraductal papillary mucinous neoplasm (IPMN)-derived pancreatic ductal adenocarcinoma (PDAC) and evaluate their prognostic value. BACKGROUND: Current guidelines recommend a minimum of 12 to 15 lymph nodes (LNs) in PDAC. This is largely based on pancreatic intraepithelial neoplasia (PanIN)-derived PDAC, a biologically distinct entity from IPMN-derived PDAC. METHODS: Multicenter retrospective study including consecutive patients undergoing upfront surgery for IPMN-derived PDAC was conducted. The minimum cutoff for lymphadenectomy was defined as the maximum number of LNs where a significant node positivity difference was observed. Maximally selected log-rank statistic was used to derive the optimal lymphadenectomy cutoff (maximize survival). Kaplan-Meier curves and log-rank tests were used to analyze overall survival (OS) and recurrence-free survival (RFS). Multivariable Cox regression was used to determine hazard ratios (HRs) with 95% confidence intervals (CI). RESULTS: In 341 patients with resected IPMN-derived PDAC, the minimum number of LNs needed to ensure accurate nodal staging was 10 ( P =0.040), whereas ≥20 LNs was the optimal number associated with improved OS (80.3 vs 37.2 months, P <0.001). Optimal lymphadenectomy was associated with improved OS [HR: 0.57 (95% CI: 0.39-0.83)] and RFS [HR: 0.70 (95% CI: 0.51-0.97)] on multivariable Cox regression. On subanalysis, the optimal lymphadenectomy cutoffs for pancreatoduodenectomy, distal pancreatectomy, and total pancreatectomy were 20 ( P <0.001), 23 ( P =0.160), and 25 ( P =0.008). CONCLUSIONS: In IPMN-derived PDAC, lymphadenectomy with at least 10 lymph nodes mitigates understaging, and at least 20 lymph nodes is associated with improved survival. Specifically, for pancreatoduodenectomy and total pancreatectomy, 20 and 25 lymph nodes were the optimal cutoffs.
引用
- Habib JR, Rompen IF, Kaslow SR, et al. Defining the Minimal and Optimal Thresholds for Lymph Node Resection and Examination for Intraductal Papillary Mucinous Neoplasm-derived Pancreatic Cancer: A Multicenter Retrospective Analysis. Ann Surg. 2024. PMID: 38606874. doi:10.1097/SLA.0000000000006295
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。